Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (121-130 of 427) with videos related to

Pageof 43
Sort By:
Asia-Pacific Journal of Clinical Oncology|January 3, 2013
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in AustraliaGiao Tran, Stephen P Hack, Annette Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive dataKathryn M Field, Matthew Croxford, Ian Hastie, et al.
Diseases of the Colon and Rectum|September 8, 2016
Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival OutcomesMurtaza Jamnagerwalla, Rebecca Tay, Malcolm Steel, et al.
Contemporary Clinical Trials|July 6, 2022
Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping reviewKhic-Houy Prang, Bill Karanatsios, Ebony Verbunt, et al.
ANZ Journal of Surgery|July 3, 2004
Carcinoma of the anal canal: a local experience and review of the literatureShirley Wong, Peter Gibbs, Michael Chao, et al.
ANZ Journal of Surgery|June 4, 2005
Preoperative chemotherapy and radiotherapy for locally advanced rectal cancerMichael Chao, Peter Gibbs, Joe Tjandra, et al.
ANZ Journal of Surgery|March 27, 2013
Second primary colorectal cancer in the era of prevalent screening and imagingSusie Bae, Muslim Asadi, Ian Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2008
Cytosine methylation profiling of cancer cell linesMathias Ehrich, Julia Turner, Peter Gibbs, et al.
BMC Cancer|December 10, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX studyPeter Gibbs, Val Gebski, Mark Van Buskirk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2024
Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Line in AustraliaKoen Degeling, Yat Hang To, Karen Trapani, et al.
Pageof 43

Showing results (121-130 of 427) with videos related to

Sort By:
Pageof 43
Asia-Pacific Journal of Clinical Oncology|January 3, 2013
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in AustraliaGiao Tran, Stephen P Hack, Annette Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive dataKathryn M Field, Matthew Croxford, Ian Hastie, et al.
Diseases of the Colon and Rectum|September 8, 2016
Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival OutcomesMurtaza Jamnagerwalla, Rebecca Tay, Malcolm Steel, et al.
Contemporary Clinical Trials|July 6, 2022
Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping reviewKhic-Houy Prang, Bill Karanatsios, Ebony Verbunt, et al.
ANZ Journal of Surgery|July 3, 2004
Carcinoma of the anal canal: a local experience and review of the literatureShirley Wong, Peter Gibbs, Michael Chao, et al.
ANZ Journal of Surgery|June 4, 2005
Preoperative chemotherapy and radiotherapy for locally advanced rectal cancerMichael Chao, Peter Gibbs, Joe Tjandra, et al.
ANZ Journal of Surgery|March 27, 2013
Second primary colorectal cancer in the era of prevalent screening and imagingSusie Bae, Muslim Asadi, Ian Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2008
Cytosine methylation profiling of cancer cell linesMathias Ehrich, Julia Turner, Peter Gibbs, et al.
BMC Cancer|December 10, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX studyPeter Gibbs, Val Gebski, Mark Van Buskirk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2024
Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Line in AustraliaKoen Degeling, Yat Hang To, Karen Trapani, et al.
Pageof 43